When conducting a follistatin peptide online aankoop (online research peptide procurement), verified sequence integrity and rigorous analytical purity are mandatory. High-grade Follistatin compounds are intended strictly for in vitro assays and animal models to evaluate TGF-beta signaling, myostatin inhibition, and cellular proliferation pathways.
When conducting a follistatin peptide online aankoop (online research peptide procurement), verified sequence integrity and rigorous analytical purity are mandatory. High-grade Follistatin compounds are intended strictly for in vitro assays and animal models to evaluate TGF-beta signaling, myostatin inhibition, and cellular proliferation pathways.
Follistatin (FST) is an autocrine glycoprotein expressed in nearly all vascularized tissues, where it functions as a potent antagonist to members of the transforming growth factor-beta (TGF-beta) superfamily. Discovered initially in follicular fluid as an inhibitor of follicle-stimulating hormone (FSH) secretion, modern biochemical investigation focuses primarily on its high-affinity binding to activin A and myostatin (growth differentiation factor 8, or GDF-8). By neutralizing these regulatory ligands, Follistatin modulates downstream Smad transcription factor cascades, altering gene expression profiles governing cellular growth, differentiation, and tissue remodeling.
For investigators seeking to execute a verified follistatin peptide online aankoop, establishing analytical transparency and structural validation is essential. Preclinical researchers utilize recombinant human Follistatin derivatives to explore skeletal muscle biology, fibrosis attenuation, and metabolic regulation. Because minor alterations in amino acid sequence or secondary structure can drastically modify receptor affinity and biological half-life, laboratory procurement demands strict adherence to rigorous quality standards, including reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry (MS) characterization.
Follistatin exists in several distinct isoforms generated via alternative splicing and post-translational proteolysis. The primary precursor transcript encodes a 344-amino acid protein (FST-344). Upon proteolytic processing at the C-terminus, FST-344 yields the circulating FST-315 isoform, which comprises the predominant endogenous variant circulating in serum. Alternatively, splicing that omits exon 6 generates FST-288, a tissue-bound isoform characterized by a highly basic heparin-binding domain that exhibits strong affinity for cell-surface glycosaminoglycans.
In experimental settings, FST-344 research peptides are frequently selected due to their extended systemic persistence and robust neutralization capacity against endogenous GDF-8 and activin complexes. The presence of the C-terminal sequence alters heparin-binding kinetics, allowing researchers to evaluate systemic versus localized tissue sequestration. Understanding these structural differences is critical when selecting specific isoforms from our research peptide catalog to ensure that the chosen reagent matches the intended receptor-binding kinetics of the assay.
The primary biochemical mechanism of Follistatin involves stoichiometric binding to activin A, activin B, and myostatin. Mechanistically, Follistatin molecules wrap around the dimeric ligands, effectively masking the receptor-binding epitopes required for interaction with type I and type II activin receptor complexes (ActRIIA and ActRIIB). In vitro cell culture models demonstrate that this binding prevents the phosphorylation of intracellular Smad2 and Smad3 proteins, thereby silencing downstream transcriptional programs that restrict muscle lineage differentiation and extracellular matrix deposition.
In animal models, preclinical administration of exogenous Follistatin variants has been shown to induce marked hypertrophy of fast-twitch glycolytic muscle fibers without altering cardiac muscle tissue architecture. In vitro assays using C2C12 myoblasts further indicate that myostatin blockade by Follistatin upregulates myogenic regulatory factors such as MyoD, Myogenin, and MRF4. Researchers investigating hypertrophic signaling cascades frequently compare these responses against other regulatory peptide pathways, such as those activated by IGF-1 LR3 or growth hormone secretagogues.
Executing a compliant follistatin peptide online aankoop requires rigorous evaluation of vendor testing protocols. Because recombinant proteins and synthetic peptides can harbor synthesis byproducts, truncated sequences, or bacterial residual impurities, every lot must undergo independent testing at an ISO 17025-accredited laboratory prior to release. Researchers must verify that analytical documentation confirms both chemical identity and high purity thresholds.
At PX1 Research, every batch of Follistatin undergoes reverse-phase HPLC to confirm a purity profile of ≥98%, ensuring that extraneous peptide fragments do not alter receptor-binding assays. Mass spectrometry (ESI-MS or MALDI-TOF) is conducted concurrently to confirm exact molecular weight match against theoretical values. Crucially, given that Follistatin is often deployed in cell culture and preclinical rodent models sensitive to pyrogens, lot-specific Certificate of Analysis (COA) documents must confirm endotoxin levels below strictly controlled limits (<0.01 EU/mg) using Chromogenic LAL assays.
Procuring peptides for advanced laboratory applications requires total confidence in manufacturing standards. PX1 Research synthesizes and processes its peptides within state-of-the-art, GMP-compliant facilities located exclusively in the United States. Operating out of primary fulfillment hubs in California and Arizona, PX1 guarantees rapid, climate-controlled dispatch (same-day shipping M–F) to protect heat-sensitive tertiary protein structures from degradation during transport.
Unlike unverified foreign distributors, PX1 Research provides full lot traceability with publicly accessible, third-party COAs for every order. Institutional laboratories and academic facilities establishing a bulk research account receive complete documentation packages, including raw chromatography data and spectral analysis. This commitment ensures that experimental variables remain tightly controlled across long-term, longitudinal studies.
To contextualize the signaling profile of Follistatin within broader biochemical research, investigators often compare its myostatin-inhibitory activity against other peptide classes that modulate tissue growth, cellular repair, and pituitary secretion. While Follistatin acts primarily through ligand neutralization within the TGF-beta pathway, growth factor analogs and secretagogues operate through distinct transmembrane receptor systems.
For example, while follistatin-344 directly sequesters myostatin and activin, compounds such as IGF-1 LR3 activate the RTK/Akt/mTOR pathway to stimulate protein synthesis directly. Simultaneously, growth hormone-releasing factor analogs like CJC-1295 DAC act on the pituitary GHRH receptor to stimulate pulsatile GH release, indirectly elevating systemic IGF-1 levels. Evaluating these distinct mechanism pathways allows researchers to design controlled comparative trials examining synergistic cellular responses in vitro.
Lyophilized Follistatin peptides require standardized reconstitution techniques to preserve secondary and tertiary structural conformation. Upon receiving the vacuum-sealed glass vial, the peptide should be allowed to equilibrate to room temperature inside a laminar flow hood before reconstitution. Reconstitution should be performed using sterile, bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of the downstream assay.
The diluent should be gently injected along the inner glass wall of the vial rather than sprayed directly onto the lyophilized cake. Gentle side-to-side swirling should be employed to dissolve the powder; vigorous shaking or vortexing must be strictly avoided, as mechanical shear stress can denature complex peptide chains and induce irreversible aggregation. Aliquoting into single-use microcentrifuge tubes immediately following reconstitution prevents degradation caused by repeated freeze-thaw cycles.
Proper storage conditions are essential for maintaining the biological activity of lyophilized and reconstituted Follistatin compounds. Unreconstituted lyophilized vials should be stored at -20°C or -80°C in a manual defrost freezer protected from light exposure. Under these conditions, the peptide retains structural stability for extended periods as specified on the batch documentation.
Once reconstituted in sterile aqueous buffers, liquid aliquots should be maintained at 4°C for short-term use (not exceeding 7–14 days) or stored at -80°C for long-term storage. Researchers conducting quantitative assays, such as Western blots or ELISA binding studies, should consult our comprehensive myostatin inhibition research guide for detailed protocol parameters regarding buffer compatibility and working concentrations.
Procurement managers and principal investigators seeking a secure follistatin peptide online aankoop must evaluate supplier integrity beyond surface-level claims. Reliable research chemical vendors must disclose their manufacturing country of origin, provide lot-matched testing data, and offer clear technical documentation for laboratory handling.
PX1 Research serves as a trusted domestic supply partner for university laboratories, biotechnology enterprises, and independent research facilities across North America and internationally. By maintaining direct control over synthesizing, aliquoting, testing, and shipping processes, PX1 eliminates third-party supply chain vulnerabilities and guarantees consistent reagent purity for reproducible experimental outcomes.
What is the primary application when completing a follistatin peptide online aankoop?
Follistatin peptides purchased online are strictly intended for laboratory research use only, including in vitro binding assays, receptor signaling studies, cell culture differentiation experiments, and preclinical animal models examining TGF-beta pathways.
How does PX1 Research verify the purity of its Follistatin peptides?
Every lot of Follistatin synthesized for PX1 Research undergoes rigorous testing at an independent ISO 17025 accredited laboratory using High-Performance Liquid Chromatography (RP-HPLC) to verify ≥98% purity and Mass Spectrometry (MS) to confirm exact molecular weight integrity.
What are the structural differences between FST-344 and FST-315?
FST-344 is a precursor isoform containing 344 amino acids that undergoes post-translational modification to form FST-315, the major circulating form in vivo. FST-344 is widely used in preclinical research due to its stability and strong systemic binding affinity for myostatin and activin.
Are PX1 Research peptides tested for endotoxin content?
Yes. All PX1 Research peptides undergo quantitative Chromogenic LAL endotoxin testing to ensure levels remain well below standard laboratory thresholds (<0.01 EU/mg), making them suitable for sensitive cell culture and animal tissue studies.
How should lyophilized Follistatin be stored upon arrival?
Lyophilized Follistatin should be stored in a freezer at -20°C or -80°C away from moisture and light. After reconstitution, single-use aliquots should be stored at -80°C to prevent degradation from repeated freeze-thaw cycles.
What solvent is recommended for reconstituting Follistatin for laboratory assays?
Reconstitution is typically performed using sterile bacteriostatic water for multi-use laboratory procedures or sterile 0.9% saline/PBS (pH 7.4) for immediate cell culture applications, following standard sterile lab techniques.
Where are PX1 Research peptides manufactured and shipped from?
All PX1 Research compounds are manufactured in GMP-compliant facilities in the USA and shipped directly from fulfillment centers in California and Arizona with same-day dispatch for orders placed Monday through Friday.
Can Follistatin peptides be used for clinical or human administration?
No. All compounds provided by PX1 Research are strictly for in vitro, biochemical, and preclinical laboratory research. They are not intended for human consumption, clinical trials, therapeutic diagnostic use, or veterinary administration.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.